Heart Test Laboratories Inc Common Stock (HSCS) had the highest return in Q2 2022 by a US stock in the Nasdaq Composite (IXIC), returning 551,076.5%.

ASSET	QUARTER	% RETURN
Heart Test Laboratories Inc Common Stock (HSCS)	Q2 2022	551,076.47%
Lottery (SEGG)	Q2 2022	7,732.17%
Foremost Lithium Resource & Technology Ltd Common stock (FMST)	Q2 2022	2,158.33%
Electra Battery Materials (ELBM)	Q2 2022	1,080.7%
China SXT Pharmaceuticals (SXTC)	Q2 2022	557.89%
Fujian Blue Hat Interactive Entertainment Technology (BHAT)	Q2 2022	480.92%
Biomea Fusion (BMEA)	Q2 2022	169.82%
Gyre Therapeutics (GYRE)	Q2 2022	157.97%
Belite Bio Inc ADR (BLTE)	Q2 2022	149.12%
TCTM Kids IT Education (VSA)	Q2 2022	140.56%
Veru (VERU)	Q2 2022	132.99%
Compass Therapeutics (CMPX)	Q2 2022	96.3%
RCM Technologies (RCMT)	Q2 2022	94.24%
Altimmune (ALT)	Q2 2022	92.12%
Alaunos Therapeutics (TCRT)	Q2 2022	90.13%
Algorhythm (RIME)	Q2 2022	88.1%
Baosheng Media (BAOS)	Q2 2022	86.67%
Day One Biopharmaceuticals (DAWN)	Q2 2022	82.47%
X3 (XTKG)	Q2 2022	81.69%
ProPhase Labs (PRPH)	Q2 2022	81.07%
SIGA Technologies (SIGA)	Q2 2022	72.84%
Harte Hanks (HHS)	Q2 2022	68.74%
DBV Technologies (DBVT)	Q2 2022	60.38%
Amylyx Pharmaceuticals (AMLX)	Q2 2022	60.23%
Wave Life Sciences (WVE)	Q2 2022	57.77%